Catalyst Pharmaceutical Partners Inc. (Nasdaq: CPRX) priced its public offering of 11.325 million common shares at the discounted price of $2.21 per share but the stock price rose 19 cents to close at $2.40.
Catalyst Pharmaceutical Prices Offering
April 03, 2014 at 17:21 PM EDT
